Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A15445 | Pages: 148 | Charts: 54 | Tables: 113 |
The global cri-du-chat syndrome treatment market was valued at $1.3 million in 2021, and is projected to reach $1.9 million by 2031, growing at a CAGR of 3.7% from 2022 to 2031. Cri-du-chat syndrome hampers growth and development and is evident at birth. Infants with this syndrome frequently have a high-pitched, feline-like scream, a small head, and distinctive facial features. Common signs include a peculiar cry that sounds like a cat meowing, distinctive facial traits, delayed growth, and microcephaly, which is characterized by a smaller head size than would be typical for an infant's age and sex.
[COVIDIMPACTSTATEMENT]
Get more information on this report : Request Sample Pages
A small percentage of babies with the cri-du-chat syndrome are born with fatal consequences, including major organ problems (particularly heart or kidney defects). The majority of fatal problems happen before the child turns one. Some of the genes on Chromosome 5 are absent in children with the cri-du-chat syndrome, typically for unclear causes. Each child will experience this differently, but the majority of them will experience delayed development and some level of intellectual handicap.
In the last decade, there has been a significant increase in awareness among the population about physiotherapy. The increase in the prevalence of cri-du-chat syndrome and out-of-pocket healthcare expenditure has led to a significant rise in healthcare costs.All these factors are driving the the cri-du-chat syndrome treatment market growth. The rise in new services for physical therapy, such as pre-recorded video material and computer or video calls, further boosts the cri-du-chat syndrome treatment market opportunity.
According to the National Organization for Rare Diseases, more women suffer from cri-du-chat syndrome than men. 1 in15,000 to 50,000 children are born with cri-du-chat syndrome average per year. It can be challenging to estimate the true prevalence of cri-du-chat syndrome in the general community because some cases may go undetected.
Despite increased awareness, healthcare users are not fully aware of the effective employment of physiotherapy because it is still in its infancy. This increases the price of physiotherapy,which hinders the market growth. Conversely, the rising purchasing power ofpeople in emerging economies in the Asia-Pacific and LAMEA regions providesone of the highest growth potentials for the cri-du-chat syndrome treatment market. In addition, regulatory authorities in developing nations have taken significant steps to amend the laws governing cri-du-chat syndrome due to rise in awareness of physiotherapy among people.
Impact of COVID-19
During the pandemic,due to the guidelines for maintaining social distancing, many patients managed the disease through self-medication or non-medically-approved strategies. During the lockdown,the slowdown of manufacturing, logistics, and transportation activities disruptedthe supply chain, which impeded market growth. People suffering from cri-du-chat syndrome confined themselves at home due to fear of getting infected by COVID. Thus, the COVID-19 outbreak had a negative impact on the growth of the global cri-du-chat syndrome treatment market share. However, vaccination drive is expected to bring stabilization to the cri-du-chat syndrome treatment market forecast.
Market Segmentation
The cri-du-chat syndrome treatment market is segmented on the basis of treatment, end user, and region. On the basis of product, the market is categorized into physiotherapy, speech therapy, and occupation therapy. On the basis of end user, it is segmented into hospitals & specialty clinics, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
Segment Review
On the basis of treatment, the cri-du-chat syndrome treatment market size is segmented into physiotherapy, occupation therapy, and speech therapy. The physiotherapy segment generated maximum revenue in 2021 and is also expected to witness the highest CAGR during the forecast period, owing to the rise in awareness about physiotherapy and its advantages.
[TREATMENTGRAPH]
On the basis of end user, the cri-du-chat syndrome treatment market size is divided into hospitals &specialty clinics and others. The hospitals &specialty clinics segment dominated the market in 2021,owing to the fact that hospitals provide higher capacity for both outpatients and inpatients. The others segment is expected to register the highest CAGR during the forecast period, owing to rise in demand for remote private care services.
[ENDUSERGRAPH]
North America accounted for a majority of the global cri-du-chat syndrome treatment market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to technological advancements in physiotherapy techniques, rise in awareness about physiotherapy treatment for cri-du-chat syndrome, and presence of key and robust hospital infrastructure in the region. Asia-Pacific is anticipated to witness notable growth, owing to rise in prevalence of cri-du-chat syndrome, development of healthcare infrastructure, and increase in investments and projects in the region.
[REGIONGRAPH]
The major players profiled in the report of cri-du-chat syndrome treatment industry are Hoppers Physio, Jeevam Therapy, Physiocomestoyou, Euro-Therapies, the Institute for Child Development, Blossoms Physiotherapy, Pediatric Advanced Therapy, Chatham Speech and Myo, Movement Masters Physical Therapy, and Rio Children's Hospital.
Key Market Segments
Key Market Players